VDR and neoplasm: Furthermore, vitamin D receptor (VDR) directed therapy has been shown to reprogram CAFs into a quiescent state and treatment using the VDR ligand analogue calcipotriol is reported to improve the delivery and efficacy of gemcitabine, where combination therapy significantly reduced tumor burden relative to monotherapy in both gemcitabine responsive and non-responsive PDAC mouse models [311].